Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Lexaria Bioscience Corp (LEXX)

Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Lexaria's Registered GLP-1 Study #4 Begins Dosing ACCESSWIRE - Thu Dec 19, 3:05AM CST

Registered Phase-1b 12-week study will investigate safety, diabetes control, and weight loss

LEXXW : 0.7471 (+11.51%)
LEXX : 2.23 (+0.90%)
Lexaria Forms New Scientific Advisory Board ACCESSWIRE - Wed Dec 18, 3:25AM CST

North American drug delivery development experts added to help guide Lexaria's strategic plans

LEXXW : 0.7471 (+11.51%)
LEXX : 2.23 (+0.90%)
Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience ACCESSWIRE - Tue Dec 17, 3:10AM CST

Dr. Gibson joining Lexaria's new scientific advisor board

LEXXW : 0.7471 (+11.51%)
LEXX : 2.23 (+0.90%)
Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5 ACCESSWIRE - Mon Dec 9, 3:10AM CST

Positive results in recent animal study strongly support first-ever human investigation for DehydraTECH-liraglutide

LEXXW : 0.7471 (+11.51%)
LEXX : 2.23 (+0.90%)
Insider Purchase: Chief Executive Officer of $LEXX (LEXX) Buys 22,828 Shares Quiver Quantitative, Inc. - Tue Dec 3, 11:28PM CST

RICHARD CHRISTOPHER, the Chief Executive Officer of $LEXX ($LEXX), bought 22,828 shares of the company on 12-02-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing....

LEXX : 2.23 (+0.90%)
BTV Features these Stocks to Watch: Contango Ore, First Nordic Metals, Champion Iron, Prime Mining, Lexaria Bioscience, Osisko Development, West Red Lake Gold Mines, & Surge Battery Metals Newsfile - Sat Nov 30, 10:06AM CST

Vancouver, British Columbia--(Newsfile Corp. - November 30, 2024) - On FOX Business News broadcast on Sunday, Dec 1, 2024 - BTV Business Television interviews emerging companies in the markets including:Cannot...

CTGO : 10.30 (+0.59%)
CIA.TO : 5.17 (+0.19%)
LEXX : 2.23 (+0.90%)
PRYM.TO : 1.46 (+0.69%)
Revolutionizing Healthcare: Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs ACCESSWIRE - Tue Nov 26, 3:20AM CST

Semaglutide being investigated for applications in heart disease, Alzheimer's, liver disease, and more

LEXXW : 0.7471 (+11.51%)
LEXX : 2.23 (+0.90%)
Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled ACCESSWIRE - Mon Nov 25, 3:00AM CST

DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format

LEXXW : 0.7471 (+11.51%)
LEXX : 2.23 (+0.90%)
ALL Study Groups using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria’s 12-Week GLP-1, Diabetes Animal Study ACCESSWIRE - Wed Nov 20, 3:05AM CST

DehydraTECH-liraglutide and a select DehydraTECH-CBD formulation were the top performing groups in the Study outperforming the Rybelsus® control group in both body weight-loss, by 11.53% and 10.65% respectively,...

LEXXW : 0.7471 (+11.51%)
LEXX : 2.23 (+0.90%)
Positive Partial 12-Week Blood Sugar Results from Lexaria’s GLP-1 Diabetes Animal Study ACCESSWIRE - Thu Oct 24, 8:10AM CDT

DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing blood sugar groups

LEXXW : 0.7471 (+11.51%)
LEXX : 2.23 (+0.90%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot